As the curtain closed on 2024, FDA issued a new draft guidance to assist clinical trial sponsors, investigators, and institutional review boards (“IRBs”) with defining, identifying, and reporting ...
If followed, clinical trial protocols established during the COVID-19 pandemic could allow more patients participate. The COVID-19 pandemic caused a major shift in the way that health care was ...
New guidelines have been developed to help researchers ensure that their clinical trial protocols and reports are complete, high-quality and transparent. Increased consistency across these documents ...
TARPON SPRINGS, Fla., June 2, 2025-- Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib—a ...
The lack of a mechanism to measure the workload involved in a clinical trials protocol was identified and confirmed by a literature review. To collect information on how Ontario sites were assessing ...
European regulators are warning that clinical trial protocol deviations are "unavoidable" for studies operating in Ukraine amid the Russian invasion, and companies should consider being flexible as ...
When discussing the future of clinical trials, people often focus on the promise of exciting new technologies, including artificial intelligence (AI) and predictive modeling. However, even the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results